What is #Regeneron polyclonal antibody cocktail?
Trump is receiving a two-antibody combo drug that’s currently in late-stage studies from Regeneron Pharmaceuticals Inc.
It’s given as a one-time treatment through an IV.
[…]
The drugs that Regeneron and other companies are testing are concentrated versions of specific antibodies that worked best against the coronavirus in lab and animal tests, and can be made in large, standardized doses.
They are being tested to treat newly diagnosed COVID-19 patients in hope of preventing serious disease or death, and to try to prevent infection in people at high risk of that such as nursing home residents and health workers.
No comments:
Post a Comment